title: Single-center experience with rituximab as first-line immunosuppression for acquired hemophilia.
authors.forename: J C
authors.initials: JC
authors.lastname: Boles
authors.forename: N S
authors.initials: NS
authors.lastname: Key
authors.forename: R
authors.initials: R
authors.lastname: Kasthuri
authors.forename: A D
authors.initials: AD
authors.lastname: Ma
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001323:Autoantibodies; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D000069283:Rituximab